(CercleFinance.com) – On the occasion of the publication of its annual results, Medtronic announces a quarterly dividend increased to $0.70 per share, thus marking its 47th consecutive year of increase, a dividend which will be implemented payment from July 12.
The medical equipment supplier reveals adjusted EPS (non-GAAP) down 7% to $1.46 for the last three months of its 2023-24 financial year, for almost stable revenues (+0.5%). to $8.59 billion (+5.4% on an organic basis).
‘We finished the financial year strong, with great strength in our businesses and each of our four segments showing organic revenue growth in the mid-single digit range or above,’ says CEO Geoff Martha.
Posting an adjusted EPS of $5.20 and organic revenue growth of 5.2% for the past financial year, Medtronic is targeting target ranges ranging from $5.40 to $5.50 and from $4 to $5.50 for those starting out. 5% respectively.
Copyright © 2024 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
